SterRx Norepinephrine Injection Recalled Due to Sterility Assurance Concerns
SterRx is recalling 9,360 bags of Norepinephrine 4 mg per 250 mL injection nationwide due to lack of assurance of sterility. The product is used in hospital and clinical settings to treat low blood pressure.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a critical-care injectable drug with a fundamental sterility defect. Loss of sterility assurance in parenteral products poses serious risk of infection and complications in vulnerable patients, meeting the Severe threshold even absent reported illnesses.
Plain-English summary
SterRx, LLC is recalling 9,360 bags of Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 5% Dextrose Injection, NDC 70324-451-01, distributed nationwide in the U.S.A. The recall was issued because the manufacturer cannot assure the sterility of the product.
The affected product was distributed under lot/batch codes S21192/BUV (18-Apr-22), S21205/BVH (23-Apr-22), and S21402/CCK (21-Aug-22). Norepinephrine is a prescription medication administered intravenously to treat critically low blood pressure in hospital and clinical settings.
Patients and healthcare providers who have received this product should not use it. Healthcare facilities should quarantine remaining inventory and consult with their pharmacy and medical staff regarding appropriate patient management. Questions about this recall can be directed to SterRx, LLC, located at 141 Idaho Ave., Plattsburgh, NY 12903.
The recalled product
- Product
- NOREPINEPHRINE 4 mg per 250 mL (16 mcg per mL) in 5% Dextrose Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-451-01.
- Manufacturer
- SterRx, LLC
- Category
- Drug — Injectable / Parenteral
- Hazard
- sterility-assurance
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- S21192/BUV 18-Apr-22 S21205/BVH 23-Apr-22 S21402/CCK 21-Aug-22
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27